Market cap
$9 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
6.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 3.89 | -60.75 | -80.43 | -18.36 | 2.86 |
| EBIT | -20.72 | 15.83 | -8.41 | 14.69 | 7.84 |
| Net Profit | 69.75 | 58.33 | 18.12 | 15.85 | -190.44 |
| EPS | 75.96 | 76.53 | 59.44 | 21.81 | -5.24 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -447.59 | -1,269.53 | -1,029.84 | -346.25 | -264.39 |
| Net Margin
| -- | -- | -694.19 | -- | -- |
| Return on equity
| 225.52 | 111.10 | -- | 1,106.98 | -310.98 |
| Return on Capital
| -98.30 | -80.66 | -- | -125.34 | -94.25 |
| Return on Assets
| -36.37 | -37.37 | -24.72 | -28.33 | -36.24 |
| Debt to Equity (x)
| -- | -- | 0.00 | -26.80 | -8.87 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
-125.34
|
-94.25
|
-75.31
|
-55.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
1,106.98
|
-310.98
|
-119.45
|
-65.30
|
|
Peer Median
|
-37.60
|
--
|
--
|
--
|
--
|
ROA
-24.72
Higher than Peers by 18.35
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-24.72
|
-28.33
|
-36.24
|
-44.54
|
-40.23
|
|
Peer Median
|
-43.06
|
--
|
--
|
--
|
--
|
EBIT Margin
-1,029.84
Lower than Peers by 989.12
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-1,029.84
|
-346.25
|
-264.39
|
-732.13
|
-1,766.51
|
|
Peer Median
|
-40.72
|
--
|
--
|
--
|
--
|
Net Margin
-694.19
Lower than Peers by 616.39
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-694.19
|
-220.22
|
-295.59
|
-800.77
|
-1,590.33
|
|
Peer Median
|
-77.79
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-80.43
Lower than Peers by 337.17
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-80.43
|
-0.31
|
0.87
|
0.78
|
0.80
|
|
Peer Median
|
256.74
|
--
|
--
|
--
|
--
|
EBIT Growth
-8.41
Lower than Peers by 22.46
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-8.41
|
9.52
|
32.46
|
26.22
|
1.75
|
|
Peer Median
|
14.05
|
--
|
--
|
--
|
--
|
Net Profit Growth
18.12
Higher than Peers by 4.55
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
18.12
|
48.53
|
30.96
|
10.36
|
4.16
|
|
Peer Median
|
13.57
|
--
|
--
|
--
|
--
|
EPS Growth
59.44
Higher than Peers by 26.60
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
59.44
|
0.60
|
0.49
|
0.26
|
-8.51
|
|
Peer Median
|
32.84
|
--
|
--
|
--
|
--
|
Book Value Growth
45.11
Higher than Peers by 67.63
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
45.11
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-22.52
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
-26.80
|
-8.87
|
0.95
|
0.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.20
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-0.20
|
-8.73
|
-7.55
|
0.14
|
0.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.57
Lower than Peers by 2.04
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
3.57
|
4.54
|
1.15
|
4.96
|
6.71
|
|
Peer Median
|
5.61
|
--
|
--
|
--
|
--
|
Quick Ratio
3.54
Lower than Peers by 1.98
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
3.54
|
4.48
|
1.06
|
4.95
|
6.61
|
|
Peer Median
|
5.52
|
--
|
--
|
--
|
--
|
Interest Coverage
-2.21
Higher than Peers by 0.37
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-2.21
|
-7.05
|
-118.91
|
-127.67
|
-122.78
|
|
Peer Median
|
-2.57
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
29.38
Lower than Peers by 11.23
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
29.38
|
35.76
|
26.66
|
26.96
|
47.94
|
|
Peer Median
|
40.61
|
--
|
--
|
--
|
--
|
Asset Turnover
0.04
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
0.04
|
0.13
|
0.12
|
0.06
|
0.03
|
|
Peer Median
|
0.10
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
135.80
|
75.02
|
98.42
|
215.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
90.51
|
145.41
|
78.69
|
132.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
83.28
|
231.20
|
345.76
|
502.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
143.02
|
-10.77
|
-168.66
|
-154.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
-1.13
|
-0.77
|
-0.18
|
-0.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
6.18
Higher than Peers by 3.34
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
6.18
|
-116.95
|
-8.76
|
0.35
|
0.10
|
|
Peer Median
|
2.84
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.81
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
-0.81
|
0.10
|
-0.77
|
0.75
|
0.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
9
Higher than Peers by 6
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Evogene - ADR
|
9
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3
|
--
|
--
|
--
|
--
|